scorecardresearch
Friday, August 8, 2025
TopicJohnson & Johnson

Topic: Johnson & Johnson

When a woman’s Johnson & Johnson hip implant turned out to be ‘faulty product’

In 'The Johnson & Johnson Files', Kaunain Sheriff M tells the story of how the ASR hip implant scandal was uncovered in India and how the company was brought to justice.

Johnson & Johnson to discontinue sale of talc-based baby powder from 2023 amid cancer lawsuits

J&J said it will switch to an all cornstarch-based version of the product. It has also reiterated its position that its baby powder is safe to use and 'does not cause cancer'.

Centre looking into securing part of J&J vaccine to manufacture for Indian market

J&J is unlikely to export its vaccine outside the US in the near future and the 'entire production' at Biological-E facilities in Hyderabad will be handed over to J&J, sources say.

Real vaccine crisis isn’t about AstraZeneca or J&J. It’s about distribution

Every drug maker wants to sell to rich countries, where profit margins are highest. But what of lower middle-income nations, where largest slice of the world’s population lives?

Vaccinate all teachers, but don’t cancel CBSE Board exams

ThePrint view on the most important issues, instantly.

J&J in talks with Modi govt to start clinical trials for its single-shot Covid vaccine in India

Johnson & Johnson says it has informed the Central Drugs Standard Control Organisation about its plan to start 'bridging clinical trials' soon.

What is J&J Covid vaccine that India’s Bio E will make with US help, the challenges it faces

Approved by US FDA on 28 February and WHO on 12 March, the Johnson & Johnson adenovirus vector-based vaccine does not need ultra cold temperatures.

‘No uniform test for cancer-causing substances in J&J baby products’ — drug regulator summoned

Child rights body issues summons over lack of standard testing methods to screen for presence of formaldehyde and asbestos in Johnson & Johnson’s baby shampoo and talcum powder.

US FDA approves J&J’s quick-acting nasal spray to treat suicidal people

FDA approval of J&J’s Spravato nasal spray comes at a time doctors are becoming increasingly concerned about Covid’s effect on mental health of Americans.

Now, Johnson & Johnson speeds up Covid vaccine trials in ‘race against time’

Johnson & Johnson will start human trials in the second half of July, about two months earlier than expected. Final-stage tests could begin in September.

On Camera

US has misread India. New Delhi will hedge, push back, and assert

India’s foreign policy today is driven less by Western alignment or global liberalism and more by domestic political imperatives — economic, ideological, and electoral.

Smartphones, gems, pharma: Which Indian exports will be worst hit by Trump tariffs, which will be spared

Electronics—specifically smartphones—& energy & pharma products make up 30% of Indian exports to US. 25% tariff on India came into effect Thursday, extra 25% to kick in by August-end.

Pakistan army chief Asim Munir to attend CENTCOM chief’s farewell, second visit to US in two months

Munir was earlier in America in June when he had a two-hour luncheon meeting with the US president at the White House.

Pakistan, Dhaka have played Washington well. Back home, Modi ecosystem has an inner conflict

To protect ourselves from Trumpian diplomacy, first we must introspect the bipolarity within our establishment discourse.